Clinical Trials Directory

Trials / Completed

CompletedNCT05385029

Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19

Thyroid Function Tests in Infants of COVID-19 Positive Pregnant Mothers

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
OMER B ABDELBASIT · Academic / Other
Sex
Age
Healthy volunteers

Summary

The thyroid gland has been shown to be a common target for COVID 19 virus. Babies born to mothers positive for COVID 19 infections were noticed to have elevated thyroid stimulating hormone ( TSH ) levels on screening. Thyroid function tests were monitored in these babies to determine presence of temporary or permanent thyroid disorders following COVID 19 infections during pregnancy.

Detailed description

TSH estimation is carried out in all newborn babies in Saudi Arabia as a screening test for hypothyroidism. The first babies who were born to COVID 19 positive mothers were noticed to have significantly abnormal high TSH values. All the data and studies on the effect of COVID 19 on thyroid gland are from adult literature. Hence with these results of TSH in the the newborns we designed this observational study to monitor the thyroid functions in infants of COVID 19 positive mothers born in our hospital. The study confirmed presence of abnormal TSH and free thyroxine in these babies at birth and these babies were followed further after that for evidence of thyroid disorders.Results of thyroid functions in the babies who born in the same period of the study to mothers without COVID 19 infection were also recorded.

Conditions

Interventions

TypeNameDescription
DRUGThyroxinetreatment for hypothyroidism or hyperthyroidism

Timeline

Start date
2020-05-01
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2022-05-23
Last updated
2022-05-23

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT05385029. Inclusion in this directory is not an endorsement.